HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,223,897 | +0.2% | 1,227,461 | +7.6% | 0.00% | 0.0% |
| Q2 2023 | $40,149,467 | +17.8% | 1,140,934 | +9.3% | 0.00% | 0.0% |
| Q1 2023 | $34,073,442 | -68.2% | 1,043,597 | -46.4% | 0.00% | -33.3% |
| Q4 2022 | $107,200,686 | +124.8% | 1,945,566 | +80.7% | 0.00% | 0.0% |
| Q3 2022 | $47,693,000 | +3.6% | 1,076,826 | +14.0% | 0.00% | 0.0% |
| Q2 2022 | $46,055,000 | +14.3% | 944,335 | +14.0% | 0.00% | +50.0% |
| Q1 2022 | $40,291,000 | +21.8% | 828,181 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $33,075,000 | +117.4% | 775,683 | +95.5% | 0.00% | +100.0% |
| Q3 2021 | $15,212,000 | +78.0% | 396,858 | +31.1% | 0.00% | – |
| Q2 2021 | $8,548,000 | +195.8% | 302,790 | +246.1% | 0.00% | – |
| Q1 2021 | $2,890,000 | -3.4% | 87,478 | +5.7% | 0.00% | – |
| Q4 2020 | $2,992,000 | – | 82,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |